U.S. flag

An official website of the United States government

NM_000527.5(LDLR):c.1060G>A (p.Asp354Asn) AND Familial hypercholesterolemia

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jul 3, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003074993.3

Allele description [Variation Report for NM_000527.5(LDLR):c.1060G>A (p.Asp354Asn)]

NM_000527.5(LDLR):c.1060G>A (p.Asp354Asn)

Gene:
LDLR:low density lipoprotein receptor [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19p13.2
Genomic location:
Preferred name:
NM_000527.5(LDLR):c.1060G>A (p.Asp354Asn)
HGVS:
  • NC_000019.10:g.11110771G>A
  • NG_009060.1:g.26391G>A
  • NM_000527.5:c.1060G>AMANE SELECT
  • NM_001195798.2:c.1060G>A
  • NM_001195799.2:c.937G>A
  • NM_001195800.2:c.556G>A
  • NM_001195803.2:c.679G>A
  • NP_000518.1:p.Asp354Asn
  • NP_000518.1:p.Asp354Asn
  • NP_001182727.1:p.Asp354Asn
  • NP_001182728.1:p.Asp313Asn
  • NP_001182729.1:p.Asp186Asn
  • NP_001182732.1:p.Asp227Asn
  • LRG_274t1:c.1060G>A
  • LRG_274:g.26391G>A
  • LRG_274p1:p.Asp354Asn
  • NC_000019.9:g.11221447G>A
  • NM_000527.4:c.1060G>A
Protein change:
D186N
Molecular consequence:
  • NM_000527.5:c.1060G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195798.2:c.1060G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195799.2:c.937G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195800.2:c.556G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195803.2:c.679G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial hypercholesterolemia
Identifiers:
MONDO: MONDO:0005439; MedGen: C0020445; OMIM: PS143890

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003461827Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jul 3, 2022)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I.

Nucleic Acids Res. 2007;35(13):4250-63. Epub 2007 Jun 18.

PubMed [citation]
PMID:
17576681
PMCID:
PMC1934990

Statistical features of human exons and their flanking regions.

Zhang MQ.

Hum Mol Genet. 1998 May;7(5):919-32.

PubMed [citation]
PMID:
9536098
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV003461827.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This missense change has been observed in individuals with clinical features of familial hypercholesterolemia (PMID: 29353225, 32331935; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 354 of the LDLR protein (p.Asp354Asn). This variant also falls at the last nucleotide of exon 7, which is part of the consensus splice site for this exon.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024